Molecular Diagnostics Market – Global Industry Analysis, Size, Share, Growth Trends & Forecast to 2021
Report Code: KNJ00024 No. of Pages: 117 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of diagnostics, leading to advances in research and treatment that are revolutionizing healthcare across a wide range of diseases and health conditions and has been driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost–effective testing. The global molecular diagnostics market is projected to reach more than US$ 30 Billion by 2021, at a CAGR of XX% from 2016 to 2021.The global market is mainly driven by chronic infections, growing geriatric population, increasing demand for personalized medicines, and R&D activities for biomarker identification equipped with emergence of new technology and applications. In addition, innovations in molecular diagnostics for treating cancer, government support for research and development, and high patient awareness levels are driving the growth of molecular diagnostic market North America dominates the global market of molecular diagnostics due to increasing incidence of infectious diseases and lifestyle associated diseases. North America controls more than 40% of the market share by the year 2021. Japan, China and India is expected to show high growth rates in the next six years in molecular diagnostics market. On the basis of application, Molecular oncology tests have emerged as a significant rapidly growing market segment. Oncology test controls nearly 25% market share by the year 2021. Other segments such as infectious diseases test and genetic testing is poised to be remarkable expansion in the near future. Growing demand for infectious diseases and genetic tests is an opportunity for global molecular diagnostics market. In terms of technology, Biochips/Microarrays is the fastest growing segment and is expected to boom further within the forecast period. FISH & Innovations and PCR based test is expected to grow at the highest CAGR in the coming years. On the basis of company, Roche is the leading company with more than 30% market share in the global molecular diagnostics market and is expected to hold its strong position in the market. Becton Dickinson, Myriad Genetics, Abbott and Qiagen is expected to robust market growth in the global molecular diagnostics market. The Research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically–supported and industry–validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise Molecular Diagnostics Sales & Forecast 6) Market Growth Drivers & Challenges Global Molecular Diagnostics Market has been analyzed from 6 viewpoints: 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise Molecular Diagnostics sales & Forecast 6) Market Growth Drivers & Challenges The following application segments of the molecular diagnostics market are detailed with size and six year forecast. • Infectious Disease Testing • Cardiovascular Disease Testing • Oncology Testing • Neurological Disorders Testing • Food Pathogen Detection Testing • Genetic Testing • Blood Screening • Tissue Typing (HLA Testing) • Others Molecular Testing Furthermore, the following technology segments of the molecular diagnostics market are detailed with size and six year forecast. • PCR Based Test • PCR Related Technologies • Non–PCR Test • Fish & Innovations Testing • Biochips/Microarrays • Biosensors • Molecular Imaging • Other Technologies The report analyses the market based on regions and presents the forecast in terms of value for the next six years. Regions covered in the report include: • North America • Europe • Japan • China • India • Brazil • Mexico • Korea • Rest of the world The following companies of the molecular diagnostics market are detailed with size and six year forecast. • Roche • Abbott Laboratories • Myriad Genetics • Qiagen • Cephied • Becton Dickinson • Biomerieux • Other Companies Research You Can Trust: This reports are written by our research team, a dedicated group of analysts that knows the industry inside and out. Data Sources The information contained in this report is based on secondary sources. Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. Research team seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, newspapers, books, Government official websites and other paid database sources.
Table of Contents 1. Executive Summary 2. Global Molecular Diagnostics Market & Forecast (2010 – 2021) 3. Global Molecular Diagnostics Market Share (2010 – 2021) 3.1 Molecular Diagnostics Market Share & Forecast – Country Wise 3.2 Molecular Diagnostics Market Share & Forecast – Application Wise 3.3 Molecular Diagnostics Market Share & Forecast – Technology Wise 3.4 Molecular Diagnostics Market Share & Forecast – Company Wise 4. Global Molecular Diagnostics Market – Country wise Analysis (2010 – 2021) 4.1 North America – Molecular Diagnostics Market & Forecast 4.2 Europe – Molecular Diagnostics Market & Forecast 4.3 China – Molecular Diagnostics Market & Forecast 4.4 Japan – Molecular Diagnostics Market & Forecast 4.5 India – Molecular Diagnostics Market & Forecast 4.6 Brazil – Molecular Diagnostics Market & Forecast 4.7 Mexico – Molecular Diagnostics Market & Forecast 4.8 Korea – Molecular Diagnostics Market & Forecast 4.9 Rest of the World(ROW) – Molecular Diagnostics Market & Forecast 5. Global – Molecular Diagnostics Market – Application wise Analysis (2010 – 2021) 5.1 Infectious Disease Testing Market & Forecast 5.1.1 Human Immunodeficiency Virus/ Hepatitis C(HIV/HCV) Testing Market & Forecast 5.1.2 Sexually Transmitted Diseases(STD) Testing Market & Forecast 5.1.3 Human Papillomavirus(HPV) Testing Market & Forecast 5.1.4 Hospitals Associated Infections (HAI) Testing Market & Forecast 5.2 Cardiovascular Disease Testing Market & Forecast 5.3 Oncology Testing Market & Forecast 5.4 Neurological Disorders Testing Market & Forecast 5.5 Food Pathogen Detection Testing Market & Forecast 5.6 Genetic Testing Market & Forecast 5.7 Blood Screening Market & Forecast 5.8 Tissue Typing (HLA Testing) Market & Forecast 5.9 Others Molecular Testing Market & Forecast 6. Global – Molecular Diagnostics Market – Technology wise Analysis (2010 – 2021) 6.1 PCR Based Test Market & Forecast 6.2 PCR Related Technologies Market & Forecast 6.3 Non–PCR Test Market & Forecast 6.4 Fish & Innovations Testing Market (Fluorescent in–situ hybridization) & Forecast 6.5 Biochips/Microarrays Market & Forecast 6.6 Biosensors Market & Forecast 6.7 Molecular Imaging Market & Forecast 6.8 Other Technologies Market & Forecast 7. Global – Molecular Diagnostics Sales Analysis – Company wise 7.1 Roche – Molecular Diagnostics Sales & Forecast 7.2 Abbott Laboratories – Molecular Diagnostic Sales & Forecast 7.3 Myriad Genetics – Molecular Diagnostic Sales & Forecast 7.4 Qiagen – Molecular Diagnostic Sales & Forecast 7.5 Cephied – Molecular Diagnostic Sales & Forecast 7.6 Becton Dickinson – Molecular Diagnostic Sales & Forecast 7.7 Biomerieux – Molecular Diagnostic Sales & Forecast 7.8 Others Company – Molecular Diagnostic Sales & Forecast 8. Global Molecular Diagnostics Market – Growth Drivers 8.1 Newer Technologies and Inventions for the Accurate Detection in the Laboratory fuel the Molecular Diagnostics Market 8.2 Personalized Medicine Bolsters the Molecular Diagnostics Market 8.3 Molecular Diagnostics: On the Edge of Major Transformation 9. Global Molecular Diagnostics Market – Challenges 9.1 Issues for the Development of Molecular Diagnostics Market 9.2 Complex Regulatory Framework Topple the Growth of the Molecular Diagnostics Market List of Tables: Table 3–1: By Country – Molecular Diagnostics Market Share(Percent),2010 – 2015 Table 3–2: By Country – Forecast for Molecular Diagnostics Market Share(Percent),2016 – 2021 Table 3–3: By Application – Molecular Diagnostics Market Share(Percent),2011 – 2015 Table 3–4: By Application – Forecast for Molecular Diagnostics Market Share(Percent),2016 – 2021 Table 3–5: By Technology – Molecular Diagnostics Market Share(Percent),2010 – 2015 Table 3–6: By Technology – Forecast for Molecular Diagnostics Market Share(Percent),2016 – 2021 Table 3–7: Global Molecular Diagnostics – Company Wise Market Share (Percent), 2010 – 2015 Table 3–8: Global Molecular Diagnostics – Forecast for Company Wise Market Share (Percent), 2016 – 2021 List of Figures: Figure 2–1: Global – Molecular Diagnostics Market (Million US$), 2010 – 2015 Figure 2–2: Global – Forecast for Molecular Diagnostics Market (Million US$), 2016 – 2021 Figure 4–1: North America – Molecular Diagnostics Market (Million US$), 2010 – 2015 Figure 4–2: North America – Forecast for Molecular Diagnostics Market (Million US$), 2016 – 2021 Figure 4–3: Europe – Molecular Diagnostics Market (Million US$), 2010 – 2015 Figure 4–4: Europe – Forecast for Molecular Diagnostics Market (Million US$), 2016 – 2021 Figure 4–5: China – Molecular Diagnostics Market (Million US$), 2010 – 2015 Figure 4–6: China – Forecast for Molecular Diagnostics Market (Million US$), 2016 – 2021 Figure 4–7: Japan – Molecular Diagnostics Market (Million US$), 2010 – 2015 Figure 4–8: Japan – Forecast for Molecular Diagnostics Market (Million US$), 2016 – 2021 Figure 4–9: India – Molecular Diagnostics Market (Million US$), 2010 – 2015 Figure 4–10: India – Forecast for Molecular Diagnostics Market (Million US$), 2016 – 2021 Figure 4–11: Brazil – Molecular Diagnostics Market (Million US$), 2007 – 2015 Figure 4–12: Brazil – Forecast for Molecular Diagnostics Market (Million US$), 2016 – 2021 Figure 4–13: Mexico – Molecular Diagnostics Market (Million US$), 2007 – 2015 Figure 4–14: Mexico – Forecast for Molecular Diagnostics Market (Million US$), 2016 – 2021 Figure 4–15: Korea – Molecular Diagnostics Market (Million US$), 2012 – 2015 Figure 4–16: Korea – Forecast for Molecular Diagnostics Market (Million US$), 2016 – 2021 Figure 4–17: Rest of the World – Molecular Diagnostics Market (Million US$), 2010 – 2015 Figure 4–18: Rest of World – Forecast for Molecular Diagnostics Market (Million US$), 2016 – 2021 Figure 5–1: Global – Infectious Disease Testing Market (Million US$), 2011 – 2015 Figure 5–2: Global – Forecast for Infectious Disease Testing Market (Million US$), 2016 – 2021 Figure 5–3: Global – HIV/HCV Testing Market (Million US$), 2009 – 2015 Figure 5–4: Global – Forecast for HIV/HCV Testing Market (Million US$), 2016 – 2021 Figure 5–5: Global – Sexually Transmitted Diseases(STD) Testing Market (Million US$),2009 – 2015 Figure 5–6: Global – Forecast for STD Testing Market (Million US$),2016 – 2021 Figure 5–7: Global – Human Papillomavirus(HPV) Testing Market (Million US$),2009 – 2015 Figure 5–8: Global – Forecast for Human Papillomavirus(HPV) Testing Market (Million US$),2016 – 2021 Figure 5–9: Global – Hospitals Associated Infections (HAI) Testing Market (Million US$),2011 – 2015 Figure 5–10: Global – Forecast for Hospitals Associated Infections (HAI) Testing Market (Million US$),2016– 2021 Figure 5–11: Global – Cardiovascular Disease Testing Market (Million US$), 2010 – 2015 Figure 5–12: Global – Cardiovascular Disease Testing Market (Million US$), 2016 – 2021 Figure 5–13: Global – Oncology Testing Market (Million US$), 2010 – 2015 Figure 5–14: Global – Forecast for Oncology Testing Market (Million US$), 2016 – 2021 Figure 5–15: Global – Neurological Disorders Testing Market (Million US$), 2010 – 2015 Figure 5–16: Global – Forecast for Neurological Disorders Testing Market (Million US$), 2016 – 2021 Figure 5–17: Global – Food Pathogen Detection Testing Market (Million US$), 2010 – 2015 Figure 5–18: Global – Forecast for Food Pathogen Detection Testing Market (Million US$), 2016 – 2021 Figure 5–19: Global – Genetic Testing Market (Million US$), 2010 – 2015 Figure 5–20: Global – Forecast for Genetic Testing Market (Million US$), 2016 – 2021 Figure 5–21: Global – Blood Screening Market (Million US$), 2007 – 2015 Figure 5–22: Global – Forecast for Blood Screening Market (Million US$), 2016 – 2021 Figure 5–23: Global – Tissue Typing Market (Million US$), 2011 – 2015 Figure 5–24: Global – Forecast for Tissue Typing Market (Million US$), 2016 – 2021 Figure 5–25: Global – Others Molecular Testing Market (Million US$), 2011 – 2015 Figure 5–26: Global – Forecast for Others Molecular Testing Market (Million US$), 2016 – 2021 Figure 6–1: Global – PCR Based Test Market (Million US$), 2010 – 2015 Figure 6–2: Global – Forecast for PCR Based Test Market (Million US$), 2016 – 2021 Figure 6–3: Global – PCR Related Technologies Market (Million US$), 2010 – 2015 Figure 6–4: Global – Forecast for PCR Related Technologies Market (Million US$), 2016 – 2021 Figure 6–5: Global – Non–PCR Test Market (Million US$), 2010 – 2015 Figure 6–6: Global – Forecast for Non–PCR Test Market (Million US$), 2016 – 2021 Figure 6–7: Global – Fish & Innovations Market (Million US$), 2010 – 2015 Figure 6–8: Global – Forecast for Fish & Innovations Market (Million US$), 2016 – 2021 Figure 6–9: Global – Biochips/ Microarrays Market (Million US$), 2010 – 2015 Figure 6–10: Global – Forecast for Biochips/ Microarrays Market (Million US$), 2016 – 2021 Figure 6–11: Global – Biosensors Market (Million US$), 2010 – 2015 Figure 6–12: Global – Forecast for Biosensors Market (Million US$), 2016 – 2021 Figure 6–13: Global – Molecular Imaging Market (Million US$), 2010 – 2015 Figure 6–14: Global – Forecast for Molecular Imaging Market (Million US$), 2016 – 2021 Figure 6–15: Global – Other Technologies Market (Million US$), 2010 – 2015 Figure 6–16: Global – Forecast for Other Technologies Market (Million US$), 2016 – 2021 Figure 7–1: Roche – Molecular Diagnostic Sales (Million US$), 2008 – 2015 Figure 7–2: Roche – Forecast for Molecular Diagnostic Sales (Million US$), 2016 – 2021 Figure 7–3: Abbott Laboratories – Molecular Diagnostic Sales (Million US$), 2010 – 2015 Figure 7–4: Abbott Laboratories – Forecast for Molecular Diagnostic Sales (Million US$), 2016 – 2021 Figure 7–5: Myriad Genetics – Molecular Diagnostic Sales (Million US$), 2007 – 2015 Figure 7–6: Myriad Genetics – Forecast for Molecular Diagnostic Sales (Million US$), 2016 – 2021 Figure 7–7: Qiagen – Molecular Diagnostic Sales (Million US$), 2010 – 2015 Figure 7–8: Qiagen – Forecast for Molecular Diagnostic Sales (Million US$), 2016 – 2021 Figure 7–9: Cepheid – Molecular Diagnostic Sales (Million US$), 2010 – 2015 Figure 7–10: Cepheid – Forecast for Molecular Diagnostic Sales (Million US$), 2016 – 2021 Figure 7–11: Becton Dickinson – Molecular Diagnostic Sales (Million US$), 2010 – 2015 Figure 7–12: Becton Dickinson – Forecast for Molecular Diagnostic Sales (Million US$), 2016 – 2021 Figure 7–13: Biomerieux – Molecular Diagnostic Sales (Million US$), 2010 – 2015 Figure 7–14: Biomerieux – Forecast for Molecular Diagnostic Sales (Million US$), 2016 – 2021 Figure 7–15: Others Company – Molecular Diagnostic Sales (Million US$), 2010 – 2015 Figure 7–16: Others Company – Forecast for Molecular Diagnostic Sales (Million US$), 2016 – 2021
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com